Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide treatment

Gerhardt Attard*, Michael Borre, Howard Gurney, Yohann Loriot, Corina Andresen-Daniil, Ranjith Kalleda, Trinh Pham, Mary Ellen Taplin, on behalf of PLATO collaborators

*Corresponding author for this work

Research output: Contribution to journalArticle

45 Citations (Scopus)
15 Downloads (Pure)

Fingerprint Dive into the research topics of 'Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences